The article presents the results of clinical studies of responsiveness of bipolar patients to lithium, lamotrigine and olanzapine in long-term stabilizing monotherapy. Different clinical profiles of responders are described.
Current practice of combination vs. monotherapy and treatment approaches to breakthrough episodes in bipolar disorders are discussed.